North America Cannabidiol (CBD) Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End-use (Medical, Personal Use), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Source Type
                        1.2.2. Sales Type
                        1.2.3. End-use
                        1.2.4. Regional scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Source type outlook
                        2.2.2. Sales type outlook
                        2.2.3. End-use outlook
                        2.2.4. Country outlook
                    2.3. Competitive Insights
Chapter 3. North America Cannabidiol Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Growing legalization of CBD-based products
                            3.2.1.2. Increasing preference for cannabis oils and tinctures
                            3.2.1.3. Growing adoption of CBD-based products for treating various medical conditions
                            3.2.1.4. Rise in number of retailers selling CBD-based products
                        3.2.2. Market restraint analysis
                            3.2.2.1. Stringent government regulations
                            3.2.2.2. High cost of CBD in leading markets
                    3.3. North America Cannabidiol Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                        3.3.2. PESTEL Analysis
                    3.4. COVID-19 Impact Analysis
Chapter 4. North America Cannabidiol Market: Source Type Estimates & Trend Analysis
                    4.1. North America Cannabidiol Market: Source Type Dashboard
                    4.2. North America Cannabidiol Market: Source Type Movement Analysis
                    4.3. North America Cannabidiol Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Hemp
                        4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    4.5. Marijuana
                        4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. North America Cannabidiol Market: Sales Type Estimates & Trend Analysis
                    5.1. North America Cannabidiol Market: Sales Type Dashboard
                    5.2. North America Cannabidiol Market: Sales Type Movement Analysis
                    5.3. North America Cannabidiol Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Business to Business (B2B)
                        5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    5.5. Business to Consumer (B2C)
                        5.5.1. Hospital Pharmacies
                            5.5.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.2. Online Stores
                            5.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Retail Stores
                            5.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. North America Cannabidiol Market: End-use Estimates & Trend Analysis
                    6.1. North America Cannabidiol Market: End-use Dashboard
                    6.2. North America Cannabidiol Market: End-use Movement Analysis
                    6.3. North America Cannabidiol Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    6.4. Medical
                        6.4.1. Chronic Pain
                            6.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.4.2. Mental Disorders
                            6.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.4.3. Cancer
                            6.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.4.4. Others
                            6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    6.5. Personal Use
                        6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    6.6. Pharmaceutical
                        6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    6.7. Wellness
                        6.7.1. Food & Beverages
                            6.7.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.7.2. Personal care & Cosmetics
                            6.7.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.7.3. Nutraceutical
                            6.7.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.7.4. Others
                            6.7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Country Estimates & Trend Analysis by Source Type, Sales Type, End-use
                    7.1. North America Cannabidiol Market: Regional Dashboard
                    7.2. North America Cannabidiol Market: Regional Movement Analysis
                    7.3. North America Cannabidiol Market Size & Forecasts and Trend Analyses by Source Type, Sales Type, End-use, 2018 to 2030
                    7.4. North America
                        7.4.1. U.S.
                            7.4.1.1. Key country dynamics
                            7.4.1.2. Regulatory framework/ reimbursement structure
                            7.4.1.3. Competitive scenario
                            7.4.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.2. Canada
                            7.4.2.1. Key country dynamics
                            7.4.2.2. Regulatory framework/ reimbursement structure
                            7.4.2.3. Competitive scenario
                            7.4.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. List of key distributors and channel partners
                        8.3.2. Key customers
                        8.3.3. Key company market share analysis, 2023
                        8.3.4. Canopy Growth Corporation
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Tilray
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Aurora Cannabis
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. Maricann, Inc.
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. Organigram Holding, Inc.
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Isodiol International, Inc.
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Medical Marijuana, Inc.
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives
                        8.3.11. Elixinol
                            8.3.11.1. Company overview
                            8.3.11.2. Financial performance
                            8.3.11.3. Product benchmarking
                            8.3.11.4. Strategic initiatives
                        8.3.12. NuLeaf Naturals, LLC
                            8.3.12.1. Company overview
                            8.3.12.2. Financial performance
                            8.3.12.3. Product benchmarking
                            8.3.12.4. Strategic initiatives
                        8.3.13. Cannoid, LLC
                            8.3.13.1. Company overview
                            8.3.13.2. Financial performance
                            8.3.13.3. Product benchmarking
                            8.3.13.4. Strategic initiatives
                        8.3.14. CV Sciences, Inc.
                            8.3.14.1. Company overview
                            8.3.14.2. Financial performance
                            8.3.14.3. Product benchmarking
                            8.3.14.4. Strategic initiatives
                        8.3.15. CHARLOTTE’S WEB.
                            8.3.15.1. Company overview
                            8.3.15.2. Financial performance
                            8.3.15.3. Product benchmarking
                            8.3.15.4. Strategic initiatives
                        8.3.16. The Cronos Group
                            8.3.16.1. Company overview
                            8.3.16.2. Financial performance
                            8.3.16.3. Product benchmarking
                            8.3.16.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America cannabidiol market, by region, 2018 - 2030 (USD Million)
Table 3 North America cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 4 North America cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 5 North America cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 7 U.S. cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 8 U.S. cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 10 Canada cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 11 Canada cannabidiol market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 North America cannabidiol market: market outlook
Fig. 10 North America cannabidiol competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 North America cannabidiol market driver impact
Fig. 16 North America cannabidiol market restraint impact
Fig. 17 North America cannabidiol market strategic initiatives analysis
Fig. 18 North America cannabidiol market: Source type movement analysis
Fig. 19 North America cannabidiol market: Source type outlook and key takeaways
Fig. 20 Hemp market estimates and forecast, 2018 - 2030
Fig. 21 Marijuana market estimates and forecast, 2018 - 2030
Fig. 22 North America cannabidiol market: Sales type movement Analysis
Fig. 23 North America cannabidiol market: Sales type outlook and key takeaways
Fig. 24 B2B market estimates and forecasts, 2018 - 2030
Fig. 25 B2C market estimates and forecasts, 2018 - 2030
Fig. 26 North America cannabidiol market: End-use movement analysis
Fig. 27 North America cannabidiol market: End-use outlook and key takeaways
Fig. 28 Medical market estimates and forecasts, 2018 - 2030
Fig. 29 Personal use market estimates and forecasts, 2018 - 2030
Fig. 30 Pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 31 Wellness market estimates and forecasts, 2018 - 2030
Fig. 32 North America cannabidiol market: Regional movement analysis
Fig. 33 North America cannabidiol market: Regional outlook and key takeaways
Fig. 34 North America cannabidiol market share and leading players
Fig. 35 North America market share and leading players
Fig. 36 North America: SWOT
Fig. 37 North America, by country
Fig. 38 North America
Fig. 39 North America market estimates and forecasts, 2018 - 2030
Fig. 40 U.S.
Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
Fig. 42 Canada
Fig. 43 Canada market estimates and forecasts, 2018 - 2030
Fig. 44 Market share of key market players- North America cannabidiol market